nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—bone cancer	0.889	1	CbGaD
Tadalafil—Nervous system disorder—Cisplatin—bone cancer	0.000399	0.00359	CcSEcCtD
Tadalafil—Tachycardia—Cisplatin—bone cancer	0.000397	0.00358	CcSEcCtD
Tadalafil—Skin disorder—Cisplatin—bone cancer	0.000395	0.00356	CcSEcCtD
Tadalafil—Pain in extremity—Doxorubicin—bone cancer	0.000394	0.00354	CcSEcCtD
Tadalafil—Hyperhidrosis—Cisplatin—bone cancer	0.000394	0.00354	CcSEcCtD
Tadalafil—Liver function test abnormal—Epirubicin—bone cancer	0.000393	0.00353	CcSEcCtD
Tadalafil—Orthostatic hypotension—Epirubicin—bone cancer	0.000389	0.0035	CcSEcCtD
Tadalafil—Abdominal pain upper—Epirubicin—bone cancer	0.000389	0.0035	CcSEcCtD
Tadalafil—Migraine—Doxorubicin—bone cancer	0.000387	0.00349	CcSEcCtD
Tadalafil—Breast disorder—Epirubicin—bone cancer	0.000384	0.00346	CcSEcCtD
Tadalafil—Hypotension—Cisplatin—bone cancer	0.00038	0.00342	CcSEcCtD
Tadalafil—Nasopharyngitis—Epirubicin—bone cancer	0.00038	0.00342	CcSEcCtD
Tadalafil—Face oedema—Doxorubicin—bone cancer	0.00038	0.00342	CcSEcCtD
Tadalafil—Abdominal discomfort—Methotrexate—bone cancer	0.000377	0.00339	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—bone cancer	0.000376	0.00339	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000371	0.00334	CcSEcCtD
Tadalafil—Influenza—Epirubicin—bone cancer	0.000368	0.00331	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—bone cancer	0.000368	0.00331	CcSEcCtD
Tadalafil—Paraesthesia—Cisplatin—bone cancer	0.000366	0.00329	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Methotrexate—bone cancer	0.000365	0.00329	CcSEcCtD
Tadalafil—Liver function test abnormal—Doxorubicin—bone cancer	0.000363	0.00327	CcSEcCtD
Tadalafil—Dyspnoea—Cisplatin—bone cancer	0.000363	0.00327	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—bone cancer	0.000359	0.00323	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—bone cancer	0.000359	0.00323	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—bone cancer	0.000358	0.00322	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—bone cancer	0.000356	0.0032	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—bone cancer	0.000354	0.00318	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—bone cancer	0.000352	0.00317	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Cisplatin—bone cancer	0.000351	0.00316	CcSEcCtD
Tadalafil—Infestation NOS—Methotrexate—bone cancer	0.00035	0.00315	CcSEcCtD
Tadalafil—Infestation—Methotrexate—bone cancer	0.00035	0.00315	CcSEcCtD
Tadalafil—Gastritis—Doxorubicin—bone cancer	0.000348	0.00313	CcSEcCtD
Tadalafil—Pain—Cisplatin—bone cancer	0.000348	0.00313	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000347	0.00313	CcSEcCtD
Tadalafil—Renal failure—Methotrexate—bone cancer	0.000344	0.0031	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—bone cancer	0.000342	0.00307	CcSEcCtD
Tadalafil—Conjunctivitis—Methotrexate—bone cancer	0.00034	0.00306	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—bone cancer	0.00034	0.00306	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—bone cancer	0.00034	0.00306	CcSEcCtD
Tadalafil—Sweating—Methotrexate—bone cancer	0.000336	0.00302	CcSEcCtD
Tadalafil—Haematuria—Methotrexate—bone cancer	0.000334	0.00301	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—bone cancer	0.000331	0.00298	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—bone cancer	0.00033	0.00297	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—bone cancer	0.000328	0.00295	CcSEcCtD
Tadalafil—Infestation—Epirubicin—bone cancer	0.000328	0.00295	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—bone cancer	0.000327	0.00294	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000325	0.00292	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—bone cancer	0.000322	0.0029	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—bone cancer	0.000319	0.00287	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—bone cancer	0.000319	0.00287	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000316	0.00285	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—bone cancer	0.000316	0.00284	CcSEcCtD
Tadalafil—Haemorrhage—Methotrexate—bone cancer	0.000314	0.00283	CcSEcCtD
Tadalafil—Sweating—Epirubicin—bone cancer	0.000314	0.00283	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—bone cancer	0.000313	0.00281	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—bone cancer	0.000312	0.00281	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—bone cancer	0.000311	0.00279	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—bone cancer	0.000309	0.00278	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—bone cancer	0.000308	0.00277	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—bone cancer	0.000303	0.00273	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—bone cancer	0.000303	0.00273	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000301	0.00271	CcSEcCtD
Tadalafil—Hypersensitivity—Cisplatin—bone cancer	0.0003	0.0027	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—bone cancer	0.000298	0.00268	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—bone cancer	0.000297	0.00268	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—bone cancer	0.000296	0.00266	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—bone cancer	0.000295	0.00265	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—bone cancer	0.000295	0.00265	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—bone cancer	0.000295	0.00265	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—bone cancer	0.000294	0.00265	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—bone cancer	0.000294	0.00264	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—bone cancer	0.000293	0.00264	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—bone cancer	0.000293	0.00263	CcSEcCtD
Tadalafil—Asthenia—Cisplatin—bone cancer	0.000292	0.00263	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—bone cancer	0.000292	0.00263	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—bone cancer	0.000292	0.00263	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—bone cancer	0.000291	0.00262	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—bone cancer	0.000291	0.00262	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—bone cancer	0.00029	0.00261	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—bone cancer	0.000289	0.0026	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—bone cancer	0.000289	0.0026	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—bone cancer	0.000288	0.0026	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—bone cancer	0.000286	0.00257	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—bone cancer	0.000285	0.00257	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—bone cancer	0.000284	0.00256	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—bone cancer	0.000283	0.00255	CcSEcCtD
Tadalafil—Diarrhoea—Cisplatin—bone cancer	0.000279	0.00251	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—bone cancer	0.000278	0.0025	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—bone cancer	0.000276	0.00248	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—bone cancer	0.000275	0.00247	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—bone cancer	0.000274	0.00247	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—bone cancer	0.000274	0.00246	CcSEcCtD
Tadalafil—Flushing—Epirubicin—bone cancer	0.000273	0.00246	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—bone cancer	0.000273	0.00246	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—bone cancer	0.000273	0.00246	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—bone cancer	0.000272	0.00245	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—bone cancer	0.000271	0.00244	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—bone cancer	0.00027	0.00243	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—bone cancer	0.000269	0.00242	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—bone cancer	0.000268	0.00241	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—bone cancer	0.000268	0.00241	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—bone cancer	0.000267	0.0024	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—bone cancer	0.000267	0.0024	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—bone cancer	0.000266	0.00239	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—bone cancer	0.000265	0.00239	CcSEcCtD
Tadalafil—Back pain—Methotrexate—bone cancer	0.000265	0.00238	CcSEcCtD
Tadalafil—Vomiting—Cisplatin—bone cancer	0.000259	0.00233	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—bone cancer	0.000258	0.00232	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—bone cancer	0.000258	0.00232	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—bone cancer	0.000257	0.00232	CcSEcCtD
Tadalafil—Rash—Cisplatin—bone cancer	0.000257	0.00231	CcSEcCtD
Tadalafil—Dermatitis—Cisplatin—bone cancer	0.000256	0.00231	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—bone cancer	0.000254	0.00229	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—bone cancer	0.000254	0.00228	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—bone cancer	0.000253	0.00227	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—bone cancer	0.000253	0.00227	CcSEcCtD
Tadalafil—Back pain—Epirubicin—bone cancer	0.000248	0.00223	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—bone cancer	0.000247	0.00222	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—bone cancer	0.000246	0.00222	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—bone cancer	0.000246	0.00221	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—bone cancer	0.000246	0.00221	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—bone cancer	0.000245	0.00221	CcSEcCtD
Tadalafil—Nausea—Cisplatin—bone cancer	0.000242	0.00218	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—bone cancer	0.000241	0.00217	CcSEcCtD
Tadalafil—Cough—Methotrexate—bone cancer	0.000239	0.00215	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—bone cancer	0.000239	0.00215	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—bone cancer	0.000237	0.00213	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—bone cancer	0.000233	0.0021	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—bone cancer	0.000233	0.0021	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—bone cancer	0.000233	0.0021	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000231	0.00208	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—bone cancer	0.00023	0.00207	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—bone cancer	0.00023	0.00207	CcSEcCtD
Tadalafil—Syncope—Epirubicin—bone cancer	0.00023	0.00207	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—bone cancer	0.000229	0.00206	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—bone cancer	0.000228	0.00205	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—bone cancer	0.000226	0.00204	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—bone cancer	0.000225	0.00203	CcSEcCtD
Tadalafil—Cough—Epirubicin—bone cancer	0.000224	0.00201	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—bone cancer	0.000223	0.00201	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—bone cancer	0.000222	0.002	CcSEcCtD
Tadalafil—Infection—Methotrexate—bone cancer	0.000222	0.002	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—bone cancer	0.000221	0.00199	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—bone cancer	0.000219	0.00197	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—bone cancer	0.000218	0.00196	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—bone cancer	0.000218	0.00196	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—bone cancer	0.000218	0.00196	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—bone cancer	0.000217	0.00195	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000217	0.00195	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—bone cancer	0.000216	0.00194	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—bone cancer	0.000215	0.00194	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—bone cancer	0.000213	0.00192	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—bone cancer	0.000213	0.00192	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—bone cancer	0.000213	0.00191	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—bone cancer	0.000209	0.00188	CcSEcCtD
Tadalafil—Oedema—Epirubicin—bone cancer	0.000209	0.00188	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—bone cancer	0.000209	0.00188	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—bone cancer	0.000208	0.00187	CcSEcCtD
Tadalafil—Infection—Epirubicin—bone cancer	0.000208	0.00187	CcSEcCtD
Tadalafil—Cough—Doxorubicin—bone cancer	0.000207	0.00186	CcSEcCtD
Tadalafil—Shock—Epirubicin—bone cancer	0.000206	0.00185	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—bone cancer	0.000205	0.00185	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—bone cancer	0.000205	0.00185	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—bone cancer	0.000205	0.00184	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—bone cancer	0.000204	0.00184	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000204	0.00183	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—bone cancer	0.000203	0.00183	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—bone cancer	0.000202	0.00182	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—bone cancer	0.000202	0.00182	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—bone cancer	0.000202	0.00182	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—bone cancer	0.000202	0.00182	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—bone cancer	0.000202	0.00182	CcSEcCtD
Tadalafil—Paraesthesia—Methotrexate—bone cancer	0.000201	0.00181	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.0002	0.0018	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—bone cancer	0.000199	0.00179	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—bone cancer	0.000199	0.00179	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—bone cancer	0.000199	0.00179	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—bone cancer	0.000197	0.00178	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—bone cancer	0.000197	0.00177	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—bone cancer	0.000195	0.00176	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—bone cancer	0.000193	0.00174	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—bone cancer	0.000193	0.00174	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—bone cancer	0.000193	0.00173	CcSEcCtD
Tadalafil—Infection—Doxorubicin—bone cancer	0.000192	0.00173	CcSEcCtD
Tadalafil—Pain—Methotrexate—bone cancer	0.000191	0.00172	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00019	0.00171	CcSEcCtD
Tadalafil—Shock—Doxorubicin—bone cancer	0.00019	0.00171	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—bone cancer	0.00019	0.00171	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—bone cancer	0.000189	0.0017	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—bone cancer	0.000189	0.0017	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—bone cancer	0.000188	0.00169	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—bone cancer	0.000188	0.00169	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—bone cancer	0.000187	0.00168	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—bone cancer	0.000186	0.00168	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—bone cancer	0.000186	0.00167	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—bone cancer	0.000184	0.00166	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—bone cancer	0.000183	0.00164	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—bone cancer	0.000181	0.00163	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—bone cancer	0.000181	0.00162	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—bone cancer	0.00018	0.00162	CcSEcCtD
Tadalafil—Pain—Epirubicin—bone cancer	0.000179	0.00161	CcSEcCtD
Tadalafil—Constipation—Epirubicin—bone cancer	0.000179	0.00161	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—bone cancer	0.000177	0.0016	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—bone cancer	0.000177	0.00159	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000176	0.00159	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—bone cancer	0.000175	0.00157	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—bone cancer	0.000174	0.00156	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—bone cancer	0.000172	0.00155	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—bone cancer	0.000172	0.00155	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—bone cancer	0.000171	0.00154	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—bone cancer	0.00017	0.00153	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000167	0.0015	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—bone cancer	0.000167	0.0015	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—bone cancer	0.000166	0.00149	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—bone cancer	0.000165	0.00149	CcSEcCtD
Tadalafil—Pain—Doxorubicin—bone cancer	0.000165	0.00149	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—bone cancer	0.000165	0.00149	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—bone cancer	0.000165	0.00148	CcSEcCtD
Tadalafil—Asthenia—Methotrexate—bone cancer	0.00016	0.00144	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—bone cancer	0.000158	0.00142	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—bone cancer	0.000158	0.00142	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—bone cancer	0.000154	0.00139	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—bone cancer	0.000154	0.00138	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—bone cancer	0.000153	0.00138	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—bone cancer	0.000153	0.00138	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—bone cancer	0.00015	0.00135	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—bone cancer	0.000148	0.00133	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—bone cancer	0.000148	0.00133	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—bone cancer	0.000143	0.00129	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—bone cancer	0.000143	0.00128	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—bone cancer	0.000142	0.00128	CcSEcCtD
Tadalafil—Rash—Methotrexate—bone cancer	0.000141	0.00127	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—bone cancer	0.000141	0.00127	CcSEcCtD
Tadalafil—Headache—Methotrexate—bone cancer	0.00014	0.00126	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—bone cancer	0.000139	0.00125	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—bone cancer	0.000138	0.00124	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—bone cancer	0.000137	0.00123	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—bone cancer	0.000133	0.0012	CcSEcCtD
Tadalafil—Nausea—Methotrexate—bone cancer	0.000133	0.00119	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—bone cancer	0.000132	0.00119	CcSEcCtD
Tadalafil—Rash—Epirubicin—bone cancer	0.000132	0.00119	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—bone cancer	0.000132	0.00119	CcSEcCtD
Tadalafil—Headache—Epirubicin—bone cancer	0.000131	0.00118	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—bone cancer	0.000128	0.00115	CcSEcCtD
Tadalafil—Nausea—Epirubicin—bone cancer	0.000124	0.00112	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—bone cancer	0.000123	0.00111	CcSEcCtD
Tadalafil—Rash—Doxorubicin—bone cancer	0.000122	0.0011	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—bone cancer	0.000122	0.0011	CcSEcCtD
Tadalafil—Headache—Doxorubicin—bone cancer	0.000121	0.00109	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—bone cancer	0.000115	0.00103	CcSEcCtD
